Prophylactic Treatment for Recurrent Hidradenitis Suppurativa
For recurrent hidradenitis suppurativa, tetracyclines (doxycycline or minocycline) for 12 weeks or as long-term maintenance therapy are the first-line prophylactic treatment for mild-to-moderate disease, while combination clindamycin plus rifampin serves as second-line or can be used first-line in severe disease. 1
Treatment Algorithm Based on Disease Severity
Mild-to-Moderate Disease (Hurley Stage I-II)
- Start with oral tetracyclines (doxycycline 100mg twice daily or minocycline 100mg twice daily) for a minimum 12-week course 1
- Continue as long-term maintenance therapy when appropriate to prevent recurrences 1
- The duration should balance patient benefit against antibiotic resistance risk, though recurrence after cessation is frequent 1
If tetracyclines fail or are contraindicated:
- Switch to clindamycin 300mg twice daily plus rifampin 300mg twice daily as second-line treatment 1
- This combination is effective for mild-to-moderate disease and can also serve as first-line in severe cases 1
Moderate-to-Severe Disease (Hurley Stage II-III)
For more advanced recurrent disease:
- Clindamycin plus rifampin as first-line or adjunct treatment 1
- Triple therapy with moxifloxacin, metronidazole, and rifampin as second- or third-line option 1
- Dapsone may be effective for a minority of patients as long-term maintenance, though evidence is limited 1
Adjunctive Prophylactic Measures
Topical therapy should be layered with systemic treatment:
- Topical clindamycin 1% solution/gel twice daily reduces pustules, though bacterial resistance is a concern 1
- Antibacterial washes (chlorhexidine, zinc pyrithione) based on expert consensus 1
- Resorcinol 15% cream is recommended but may cause contact dermatitis 1
For appropriate female patients, consider hormonal agents either as monotherapy for mild-to-moderate disease or combined with antibiotics:
- Combined oral contraceptives (estrogen-containing)
- Spironolactone
- Avoid progestogen-only contraceptives as they may worsen HS 1
Critical Pitfalls to Avoid
⚠️ Do not use topical clindamycin monotherapy long-term - high risk of bacterial resistance 1
⚠️ Avoid stopping antibiotics abruptly - recurrence following cessation is frequent; taper or transition to maintenance therapy 1
⚠️ Do not rely on methotrexate or azathioprine - limited evidence does not support their use in HS 1
⚠️ Avoid long-term systemic corticosteroids - only use short-term pulse therapy for acute flares or as a bridge to other treatment 1
When Medical Prophylaxis Is Insufficient
If recurrent disease persists despite optimal medical management:
- Consider IV ertapenem as one-time rescue therapy or bridge to surgery 1
- Evaluate for surgical intervention for locally recurring lesions or structurally advanced disease 2, 3
- Consider biologic therapy (adalimumab, secukinumab, bimekizumab) for moderate-to-severe inflammatory disease 4, 2
The 2019 North American guidelines 1 remain the most comprehensive framework for prophylactic antibiotic management, with the 2024-2025 updates 5, 6, 4 emphasizing the importance of treatment stacking and multimodal approaches when single-agent prophylaxis fails.